GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Gross-Profit-to-Asset %

Prestige Consumer Healthcare (FRA:PBV) Gross-Profit-to-Asset % : 19.95% (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Prestige Consumer Healthcare's annualized Gross Profit for the quarter that ended in Dec. 2024 was €615 Mil. Prestige Consumer Healthcare's average Total Assets over the quarter that ended in Dec. 2024 was €3,084 Mil. Therefore, Prestige Consumer Healthcare's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 19.95%.


Prestige Consumer Healthcare Gross-Profit-to-Asset % Historical Data

The historical data trend for Prestige Consumer Healthcare's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Gross-Profit-to-Asset % Chart

Prestige Consumer Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.06 15.18 18.14 18.07 18.58

Prestige Consumer Healthcare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.73 18.27 17.72 18.72 19.95

Competitive Comparison of Prestige Consumer Healthcare's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Consumer Healthcare's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Gross-Profit-to-Asset % falls into.



Prestige Consumer Healthcare Gross-Profit-to-Asset % Calculation

Prestige Consumer Healthcare's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=574.492/( (3132.383+3052.944)/ 2 )
=574.492/3092.6635
=18.58 %

Prestige Consumer Healthcare's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=615.208/( (2988.513+3179.67)/ 2 )
=615.208/3084.0915
=19.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Prestige Consumer Healthcare Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Consumer Healthcare Business Description

Traded in Other Exchanges
Address
660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare Headlines

No Headlines